| Literature DB >> 21995704 |
Tamsyn Sa Thring1, Pauline Hili, Declan P Naughton.
Abstract
BACKGROUND: Numerous reports have identified therapeutic roles for plants and their extracts and constituents. The aim of this study was to assess the efficacies of three plant extracts for their potential antioxidant and anti-inflammatory activity in primary human skin fibroblasts.Entities:
Year: 2011 PMID: 21995704 PMCID: PMC3214789 DOI: 10.1186/1476-9255-8-27
Source DB: PubMed Journal: J Inflamm (Lond) ISSN: 1476-9255 Impact factor: 4.981
Summary of results from collagenase, elastase, and antioxidant capacity (TEAC) (N = 6, ± SEM).
| Extract | Concentration added | % inhibition of elastase | % inhibition of collagenase | Trolox equivalent |
|---|---|---|---|---|
| WTEG | 1% | 10.57 ± 0.45 | 10.96 ± 4.82 | 5.78 ± 0.55 |
| WHD | 10% | 41.00 ± 2.38 | No activity | No activity |
| WT† | 25 μg | 89.00 ± 3.62 | 87.08 ± 4.79 | 10.62* ± 0.69 |
| RT† | 25 μg | 22.08 ± 0.64 | 40.96 ± 3.9 | 9.91** ± 0.85 |
| WH† | 25 μg | 2.8 ± 0.77 | 13.70 ± 3.26 | 13.15** ± 0.48 |
* denotes extracts diluted to 1 μg and ** 6.25 μg: † from ref [9]
Figure 1Inhibition of IL-8 release by the WT, RT, WH, WTEG and WHW. Comparisons are against control values for (N = 6 ± SEM, *P < 0.05 compared with H2O2 control). Exact % values are given for clarity. Extracts (~) were tested at 100, 50 and 25 μg final volume, WTEG was tested at 6.25, 3.125 and 1.256% and WHD at 25, 12.5, and 6.25% respectively. Legend indicates volume added in assay to yield afore-mentioned concentrations.
Figure 2Effect of treatment on IL-8 production without (wo_) and with (w_) H.
Figure 3Light microscope images of fibroblast cells (×400) with the extract and product treatments. (A-H) cells treated with 100 μg of plant extracts with and without 0.5 mM H2O2. (I-L) cells treated with 100 μg of plant extracts with and without 0.5 mM H2O2.
Cytotoxicity studies showing the % cell viability (N = 6, ± SEM) when treated with various concentrations of extracts and products using the neutral red assay.
| Product | 25% | 12.50% | 6.25% | 3.12% | 1.56% | 0.78% | 0.39% |
|---|---|---|---|---|---|---|---|
| WTEG | 1NT | 1NT | 93.84 ± 2.05 | 92.99 ± 2.24 | 98.87 ± 1.81 | 98.27 ± 2.89 | 100.66 ± 2.83 |
| WHD | 99.77 ± 0.83 | 99.88 ± 2.53 | 102.35 ± 1.21 | 101.47 ± 3.36 | 102.10 ± 3.41 | 1NT | 1NT |
| WT | 112.97 ± 1.55 | 102.39 ± 1.59 | 88.08 ± 2.03 | 83.076 ± 6.26 | 76.37 ± 5.63 | ||
| RT | 93.17 ± 4.65 | 96.67 ± 0.92 | 94.24 ± 5.77 | 92.52 ± 6.27 | 94.41 ± 7.78 | ||
| WH | 96.90 ± 2.055 | 95.57 ± 3.95 | 91.47 ± 5.77 | 101.42 ± 3.65 | 99.26 ± 2.83 | ||
1NT indicates not tested at these concentrations due to solubility ability